Education
About Us
Working with TipRanks
Follow Us
Universe Pharmaceuticals Incorporation (UPC)
:UPC
UPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.51 - $2,004.00
Previous CloseN/A
Volume250.22K
Average Volume (3M)74.19K
Market Cap
$2.10M
Enterprise Value-$38.12M
Total Cash (Recent Filing)$47.27M
Total Debt (Recent Filing)$7.73M
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Aug 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding563,338
10 Day Avg. Volume57,480
30 Day Avg. Volume74,185
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-18.14
Enterprise Value/Revenue-1.98
Enterprise Value/Gross Profit-6.36
Enterprise Value/Ebitda-21.08
Forecast
1Y Price Target
$3.50Price Target Upside-6.17% Downside
Rating ConsensusHold
Number of Analyst Covering0
Universe Pharmaceuticals News
UPC FAQ
What was Universe Pharmaceuticals Incorporation’s price range in the past 12 months?
Universe Pharmaceuticals Incorporation lowest stock price was $2.51 and its highest was $2004.00 in the past 12 months.
What is Universe Pharmaceuticals Incorporation’s market cap?
Universe Pharmaceuticals Incorporation’s market cap is $2.10M.
When is Universe Pharmaceuticals Incorporation’s upcoming earnings report date?
Universe Pharmaceuticals Incorporation’s upcoming earnings report date is Aug 04, 2025 which is 33 days ago.
How were Universe Pharmaceuticals Incorporation’s earnings last quarter?
Currently, no data Available
Is Universe Pharmaceuticals Incorporation overvalued?
According to Wall Street analysts Universe Pharmaceuticals Incorporation’s price is currently Overvalued.
Does Universe Pharmaceuticals Incorporation pay dividends?
Universe Pharmaceuticals Incorporation does not currently pay dividends.
What is Universe Pharmaceuticals Incorporation’s EPS estimate?
Universe Pharmaceuticals Incorporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Universe Pharmaceuticals Incorporation have?
Universe Pharmaceuticals Incorporation has 563,338 shares outstanding.
What happened to Universe Pharmaceuticals Incorporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Universe Pharmaceuticals Incorporation?
Currently, no hedge funds are holding shares in UPC
Company Description
Universe Pharmaceuticals Incorporation
Universe Pharmaceuticals (UPC) is a biotechnology company focused on the research, development, and commercialization of innovative pharmaceutical products. Operating primarily in the healthcare sector, UPC specializes in creating advanced therapeutics that address unmet medical needs, particularly in areas such as oncology, neurology, and infectious diseases. The company's core offerings include a pipeline of novel drug candidates, as well as partnerships for the development of generics and biosimilars.
Technical Analysis
Ownership Overview
―
Insiders
0.07% Mutual Funds
6.51% Other Institutional Investors
93.49% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---